Skip to main content

Abstract

Objective:

This study analyzed health service patterns before opioid-related death among nonelderly individuals in the Medicaid program, focusing on decedents with and without past-year diagnoses of noncancer chronic pain.

Methods:

The authors identified opioid-related decedents, age ≤64 years, in the Medicaid program and characterized their clinical diagnoses, filled medication prescriptions, and nonfatal poisoning events during the 30 days and 12 months before death. The study group included 13,089 opioid-related deaths partitioned by presence or absence of chronic noncancer pain diagnoses in the last year of life.

Results:

Most decedents (61.5%) had received clinical diagnoses of chronic noncancer pain conditions in the last year of life. As compared with decedents without chronic pain diagnoses, those with these diagnoses were significantly more likely to have filled prescriptions for opioids (49.0% versus 17.2%) and benzodiazepines (52.1% versus 26.6%) during the last 30 days of life, while diagnoses of opioid use disorder during this period were uncommon in both groups (4.2% versus 4.3%). The chronic pain group was also significantly more likely than the nonpain group to receive clinical diagnoses of drug use (40.8% versus 22.1%), depression (29.6% versus 13.0%) or anxiety (25.8% versus 8.4%) disorders during the last year of life.

Conclusions:

Persons dying of opioid-related causes, particularly those who were diagnosed with chronic pain conditions, commonly received services related to drug use disorders and mental disorders in the last year of life, though opioid use disorder diagnoses near the time of death were rare.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 538 - 544
PubMed: 29179577

History

Received: 21 July 2017
Revision received: 8 September 2017
Revision received: 22 September 2017
Accepted: 2 October 2017
Published online: 28 November 2017
Published in print: June 01, 2018

Keywords

  1. Epidemiology
  2. Psychoactive Substance Use Disorder
  3. Opioid Overdose
  4. Opioid Poisoning
  5. Opioid-Related Mortality
  6. Chronic Pain Epidemiology
  7. Drug Overdose Mortality

Authors

Details

Mark Olfson, M.D., M.P.H. [email protected]
From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York; Quartet Health, New York; the Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick; and the Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Md.
Melanie Wall, Ph.D.
From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York; Quartet Health, New York; the Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick; and the Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Md.
Shuai Wang, Ph.D.
From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York; Quartet Health, New York; the Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick; and the Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Md.
Stephen Crystal, Ph.D.
From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York; Quartet Health, New York; the Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick; and the Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Md.
Carlos Blanco, M.D., Ph.D.
From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York; Quartet Health, New York; the Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick; and the Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Md.

Notes

Address correspondence to Dr. Olfson ([email protected]).

Competing Interests

Dr. Wang is currently employed by Quartet, which is not related to the subject of the paper. Dr. Blanco owns stock in Eli Lilly, Sanofi, and General Electric. The other authors report no financial relationships with commercial interests.

Funding Information

Agency for Healthcare Research and Quality10.13039/100000133: HS021112
National Institute on Drug Abuse10.13039/100000026: DA019606

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share